Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 17 patents
facebook: 1 Facebook page

Readers on

mendeley: 113 Mendeley

So far, Altmetric has seen 17 patents that reference this research output.

Agents, uses and methods for the treatment of synucleinopathy

Grant US-12421303-B2

United States of America

23 Sep 2025

ANTI-ALPHA-SYNUCLEIN THERAPEUTIC VACCINES

Application WO-2023152260-A1

World Intellectual Property Organisation (WIPO)

17 Aug 2023

Agents, uses and methods for the treatment of synucleinopathy

Grant US-11542323-B2

United States of America

03 Jan 2023

Agents, uses and methods for the treatment of synucleinopathy

Grant US-11524995-B2

United States of America

13 Dec 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 13 additional patents.